🧭Clinical Trial Compass

Am I eligible?Pricing About

CD7 Positive R/R PTCL

Clinical trial pipeline · Data from ClinicalTrials.gov

See which CD7 Positive R/R PTCL trials you may qualify for

Filter by country

North America

Europe

Asia-Pacific

Rest of World

Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.

Clinical Trial Compass

Data sourced from ClinicalTrials.gov and OpenFDA. For informational purposes only. Always consult your healthcare provider.

Not medical advice.

1

Total trials

1

Actively recruiting

0

Phase 3 trials

0

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed PTCL.

China18 participantsStarted 2025-08-18

Treatment: CAR-T

All recent trials (1 shown)